Mahchid Bamdad

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski et al. · Oncotarget · 2016 · 116 citations · Full text

Medicine, Oncology, Pharmacology +16

Subcommissural organ/Reissner's fiber complex: Characterization of SCO-spondin, a glycoprotein with potent activity on neurite outgrowth

Stéphane Gobron, Isabelle Creveaux, R Meiniel et al. · Glia · 2000 · 88 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells

Abderrahim El Guerrab, Mahchid Bamdad, Yves‐Jean Bignon et al. · Scientific Reports · 2020 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines

Clémence Dubois, Robin Dufour, Pierre Daumar et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Cell Biology, Oncology +15

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib

Robin Dufour, Pierre Daumar, Emmanuelle Mounetou et al. · Scientific Reports · 2015 · 41 citations · Full text

Medicine, Oncology, Pharmacology +14